Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Subutex approved in Canada for opiate addiction treatment

Feb. 15, 2005

Neuropeptide Y Y2 antagonist effective in rats with ethanol dependence

Feb. 14, 2005

RiVax ricin vaccine enters clinical testing

Feb. 9, 2005

SR-147778: further evidence that CB1 antagonism may be effective for the treatment of alcoholism

Feb. 8, 2005

New varenicline formulations for smoking cessation reported by Pfizer

Feb. 4, 2005

GDNF shows promise as a novel target for treating alcohol abuse

Feb. 3, 2005

NIDA grant supports drug addiction therapy development at InfleXion

Feb. 1, 2005

Phase IIa Tetrodin study completes enrollment

Jan. 20, 2005

Campral available in U.S.

Jan. 14, 2005

Vigabatrin induces abstinence in methamphetamine, cocaine addiction

Jan. 10, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...